Association of Circulating MicroRNA-142-3p with Graves Disease

This study aims to investigate the possible role of circulating microRNA-142-3p (miR-142-3p) in the development of graves disease (GD) and its association with the antibody directed against thyroid stimulating hormone receptor (TSHR-Ab) production in patients with GD. Forty patients with positive TS...

Full description

Saved in:
Bibliographic Details
Main Authors: Rashad Ayad Al-Heety, Hayfaa S Al-Hadithi
Format: Article
Language:English
Published: University of Baghdad, College of Science for Women 2021-12-01
Series:مجلة بغداد للعلوم
Subjects:
Online Access:https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/4580
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839601974975135744
author Rashad Ayad Al-Heety
Hayfaa S Al-Hadithi
author_facet Rashad Ayad Al-Heety
Hayfaa S Al-Hadithi
author_sort Rashad Ayad Al-Heety
collection DOAJ
description This study aims to investigate the possible role of circulating microRNA-142-3p (miR-142-3p) in the development of graves disease (GD) and its association with the antibody directed against thyroid stimulating hormone receptor (TSHR-Ab) production in patients with GD. Forty patients with positive TSHR-Ab enrolled in this study were divided ,based on treatment, into (22 untreated (newly diagnosed) and 18 treated patients) and based on family history (30 with positive family history and 10 with negative family history). In addition to forty healthy subjects with sex and age matching as a control group. The expression level of circulating miR-142-3p was determined by two steps reverse transcription polymerase chain reaction (RT-PCR) technique. Results show that there is a significant elevation (p < 0.01) in the expression of miR- 142-3p in the serum of both treated and untreated patients compared with controls and in patients with positive family history compared with negative family history. While its expression is non-significantly lower (P > 0.05) in the serum of treated patients compared with untreated ones. It has been found that miR- 142-3p expression was positively correlated with levels of TSHR-Ab, FT3, and FT4. In addition, the miR- 142-3p expression has a good diagnostic accuracy with sensitivity (82%) and specificity (80%). In conclusion, the differential expression of miR-142-3p between patients and healthy controls appears as a potential biomarker for diagnosis of GD and the positive correlation of miR-142-3p with TSHR-Ab suggesting the contribution of this miRNA in the development of GD.
format Article
id doaj-art-5f3a8fca45cf4f4e88f1afac3c44a2ad
institution Matheson Library
issn 2078-8665
2411-7986
language English
publishDate 2021-12-01
publisher University of Baghdad, College of Science for Women
record_format Article
series مجلة بغداد للعلوم
spelling doaj-art-5f3a8fca45cf4f4e88f1afac3c44a2ad2025-08-02T09:09:23ZengUniversity of Baghdad, College of Science for Womenمجلة بغداد للعلوم2078-86652411-79862021-12-0118410.21123/bsj.2021.18.4.1133Association of Circulating MicroRNA-142-3p with Graves DiseaseRashad Ayad Al-Heety0Hayfaa S Al-Hadithi1Department of Medical lab. Techniques, Al-Ma’moon University College.Department of Microbiology, College of Medicine, University of Baghdad.This study aims to investigate the possible role of circulating microRNA-142-3p (miR-142-3p) in the development of graves disease (GD) and its association with the antibody directed against thyroid stimulating hormone receptor (TSHR-Ab) production in patients with GD. Forty patients with positive TSHR-Ab enrolled in this study were divided ,based on treatment, into (22 untreated (newly diagnosed) and 18 treated patients) and based on family history (30 with positive family history and 10 with negative family history). In addition to forty healthy subjects with sex and age matching as a control group. The expression level of circulating miR-142-3p was determined by two steps reverse transcription polymerase chain reaction (RT-PCR) technique. Results show that there is a significant elevation (p < 0.01) in the expression of miR- 142-3p in the serum of both treated and untreated patients compared with controls and in patients with positive family history compared with negative family history. While its expression is non-significantly lower (P > 0.05) in the serum of treated patients compared with untreated ones. It has been found that miR- 142-3p expression was positively correlated with levels of TSHR-Ab, FT3, and FT4. In addition, the miR- 142-3p expression has a good diagnostic accuracy with sensitivity (82%) and specificity (80%). In conclusion, the differential expression of miR-142-3p between patients and healthy controls appears as a potential biomarker for diagnosis of GD and the positive correlation of miR-142-3p with TSHR-Ab suggesting the contribution of this miRNA in the development of GD.https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/4580Circulating microRNAs, MicroRNA-142-3p, Graves disease, Thyroid stimulating hormone receptor antibody, Reverse transcription polymerase chain reaction
spellingShingle Rashad Ayad Al-Heety
Hayfaa S Al-Hadithi
Association of Circulating MicroRNA-142-3p with Graves Disease
مجلة بغداد للعلوم
Circulating microRNAs, MicroRNA-142-3p, Graves disease, Thyroid stimulating hormone receptor antibody, Reverse transcription polymerase chain reaction
title Association of Circulating MicroRNA-142-3p with Graves Disease
title_full Association of Circulating MicroRNA-142-3p with Graves Disease
title_fullStr Association of Circulating MicroRNA-142-3p with Graves Disease
title_full_unstemmed Association of Circulating MicroRNA-142-3p with Graves Disease
title_short Association of Circulating MicroRNA-142-3p with Graves Disease
title_sort association of circulating microrna 142 3p with graves disease
topic Circulating microRNAs, MicroRNA-142-3p, Graves disease, Thyroid stimulating hormone receptor antibody, Reverse transcription polymerase chain reaction
url https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/4580
work_keys_str_mv AT rashadayadalheety associationofcirculatingmicrorna1423pwithgravesdisease
AT hayfaasalhadithi associationofcirculatingmicrorna1423pwithgravesdisease